Showing results (141-150 of 292) with videos related to
Sort By:
Pageof 30
Clinical Pharmacology : Advances and Applications|May 19, 2021
Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant BacteriaMajed M Masadeh, Karem H Alzoubi, Majd M Masadeh, et al.Clinical Pharmacology : Advances and Applications|April 21, 2020
Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label StudyXicheng Wang, Jianfeng Zhou, Yan Li, et al.Clinical Pharmacology : Advances and Applications|March 10, 2021
Parkinson's Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]Clinical Pharmacology : Advances and Applications|March 12, 2021
Efficacy of Generic Atorvastatin in a Real-World SettingPanisa Manasirisuk, Nanthaphan Chainirun, Somsak Tiamkao, et al.Clinical Pharmacology : Advances and Applications|October 23, 2015
An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)Lance A Wollenberg, Donald T Corson, Courtney A Nugent, et al.Clinical Pharmacology : Advances and Applications|April 20, 2018
Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxibRaymond R Tjandrawinata, Arini Setiawati, Dwi Nofiarny, et al.Clinical Pharmacology : Advances and Applications|October 7, 2021
Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and RivaroxabanTakla R Anis, Whitney JandreauClinical Pharmacology : Advances and Applications|October 7, 2021
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19Prasan Kumar Panda, Budha O Singh, Bikram Moirangthem, et al.Clinical Pharmacology : Advances and Applications|October 13, 2018
Mechanisms and the clinical relevance of complex drug-drug interactionsArthur G Roberts, Morgan E GibbsClinical Pharmacology : Advances and Applications|February 28, 2022
Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A ReviewKaleab Alemayehu Zewdie, Haftom Gebregergs Hailu, Muluken Altaye Ayza, et al.Pageof 30